NCT05740007Phase 2Terminated

A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

Study sponsor: Ironwood Pharmaceuticals, Inc. · IRWD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-01-23Actual
Enrollment · participants98Actual
Source updated2025-02-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview